Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 3/2017

01-03-2017 | Original Article

Patterns and trends of pediatric bloodstream infections: a 7-year surveillance study

Authors: N. Buetti, A. Atkinson, L. Kottanattu, J. Bielicki, J. Marschall, A. Kronenberg, the Swiss Centre for Antibiotic resistance (ANRESIS)

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 3/2017

Login to get access

Abstract

We characterize the epidemiology of pediatric bloodstream infections (BSIs) in Switzerland. We analyzed pathogen distribution and resistance patterns in monomicrobial and polymicrobial BSIs in children from 2008 to 2014 using data from the Swiss antibiotic resistance centre (ANRESIS). A confirmatory statistical analysis was performed comparing pathogens and resistance across 20 acute care hospitals. We identified 3,067 bacteremia episodes, of which 1,823 (59 %) were considered true BSI episodes. Overall, S. aureus (16.5 %, 300) was the most frequent pathogen, followed by E. coli (15.1 %, 276), coagulase-negative staphylococci (CoNS, 12.9 %, 235), S. pneumoniae (11.1 %, 202) and non-E. coli Enterobacteriaceae (8.7 %, 159). S. aureus and E. coli showed similar frequencies in all of the variables analyzed (e.g., hospital acquisition, hospital type, medical specialty). The proportion of these microorganisms did not change over time, resistance rates remained low (4.3 % methicillin resistance in S. aureus; 7.3 % third-/fourth-generation cephalosporin resistance in E. coli), and no significant resistance trends were observed. We observed a 50 % increase of CoNS BSIs from 2008 (9.8 %, 27) to 2014 (15.2 %, 46, p value for trend = 0.03). S. pneumoniae decreased from 17.5 % (48) to 6.6 % (20) during that timeframe (p for trend = 0.007). S. aureus and E. coli remained the most significant pathogens among pediatric BSIs in Switzerland, exhibiting low resistance rates. CoNS accounted for a greater proportion of BSIs over time. The decrease in bacteremic pneumococcal infections can likely be attributed to the introduction of the 13-valent conjugate vaccine in 2011.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wilson J, Elgohari S, Livermore DM et al (2011) Trends among pathogens reported as causing bacteraemia in England, 2004–2008. Clin Microb Infect 17:451–458CrossRef Wilson J, Elgohari S, Livermore DM et al (2011) Trends among pathogens reported as causing bacteraemia in England, 2004–2008. Clin Microb Infect 17:451–458CrossRef
2.
go back to reference Skogberg K, Lyytikainen O, Ollgren J, Nuorti JP, Ruutu P (2012) Population-based burden of bloodstream infections in Finland. Clin Microb Infect 18:E170–E176CrossRef Skogberg K, Lyytikainen O, Ollgren J, Nuorti JP, Ruutu P (2012) Population-based burden of bloodstream infections in Finland. Clin Microb Infect 18:E170–E176CrossRef
3.
go back to reference Anderson DJ, Moehring RW, Sloane R et al (2014) Bloodstream infections in community hospitals in the 21st century: a multicenter cohort study. PLoS One 9:e91713CrossRefPubMedPubMedCentral Anderson DJ, Moehring RW, Sloane R et al (2014) Bloodstream infections in community hospitals in the 21st century: a multicenter cohort study. PLoS One 9:e91713CrossRefPubMedPubMedCentral
4.
go back to reference Henderson KL, Johnson AP, Muller-Pebody B, Charlett A, Gilbert R, Sharland M (2010) The changing aetiology of paediatric bacteraemia in England and Wales, 1998–2007. J Med Microbiol 59:213–219CrossRefPubMed Henderson KL, Johnson AP, Muller-Pebody B, Charlett A, Gilbert R, Sharland M (2010) The changing aetiology of paediatric bacteraemia in England and Wales, 1998–2007. J Med Microbiol 59:213–219CrossRefPubMed
5.
go back to reference Laupland KB, Gregson DB, Vanderkooi OG, Ross T, Kellner JD (2009) The changing burden of pediatric bloodstream infections in Calgary, Canada, 2000–2006. Pediatr Infect Dis J 28:114–117CrossRefPubMed Laupland KB, Gregson DB, Vanderkooi OG, Ross T, Kellner JD (2009) The changing burden of pediatric bloodstream infections in Calgary, Canada, 2000–2006. Pediatr Infect Dis J 28:114–117CrossRefPubMed
6.
go back to reference Larru B, Gong W, Vendetti N et al (2016) Bloodstream infections in hospitalized children: epidemiology and antimicrobial susceptibilities. Pediatr Infect Dis J 35(5):507–510 Larru B, Gong W, Vendetti N et al (2016) Bloodstream infections in hospitalized children: epidemiology and antimicrobial susceptibilities. Pediatr Infect Dis J 35(5):507–510
7.
go back to reference Bundesamt für Gesundheit (BAG), (Federal Office of Public Health) (2015) Impfempfehlungen (vaccine recommendations). Available online from: http://www.bagadminch. Accessed 25 November 2015 Bundesamt für Gesundheit (BAG), (Federal Office of Public Health) (2015) Impfempfehlungen (vaccine recommendations). Available online from: http://​www.​bagadminch. Accessed 25 November 2015
8.
go back to reference De Kraker ME, Jarlier V, Monen JC, Heuer OE, van de Sande N, Grundmann H (2013) The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System. Clin Microb Infect 19:860–868 De Kraker ME, Jarlier V, Monen JC, Heuer OE, van de Sande N, Grundmann H (2013) The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System. Clin Microb Infect 19:860–868
11.
go back to reference Asgeirsson H, Gudlaugsson O, Kristinsson KG et al (2015) Low mortality of Staphylococcus aureus bacteremia in Icelandic children: nationwide study on incidence and outcome. Pediatr Infect Dis J 34:140–144CrossRefPubMed Asgeirsson H, Gudlaugsson O, Kristinsson KG et al (2015) Low mortality of Staphylococcus aureus bacteremia in Icelandic children: nationwide study on incidence and outcome. Pediatr Infect Dis J 34:140–144CrossRefPubMed
12.
go back to reference Naidoo R, Nuttall J, Whitelaw A, Eley B (2013) Epidemiology of Staphylococcus aureus bacteraemia at a tertiary children’s hospital in Cape Town, South Africa. PLoS One 8:e78396CrossRefPubMedPubMedCentral Naidoo R, Nuttall J, Whitelaw A, Eley B (2013) Epidemiology of Staphylococcus aureus bacteraemia at a tertiary children’s hospital in Cape Town, South Africa. PLoS One 8:e78396CrossRefPubMedPubMedCentral
13.
go back to reference ECDC Surveillance Report (2015) Annual epidemiological report antimicrobial resistance and healthcare-associated infections 2014 (EARS-Net) ECDC Surveillance Report (2015) Annual epidemiological report antimicrobial resistance and healthcare-associated infections 2014 (EARS-Net)
14.
go back to reference Bielicki JA, Lundin R, Sharland M, Project A (2015) Antibiotic resistance prevalence in routine bloodstream isolates from children’s hospitals varies substantially from adult surveillance data in Europe. Pediatr Infect Dis J 34:734–741CrossRefPubMed Bielicki JA, Lundin R, Sharland M, Project A (2015) Antibiotic resistance prevalence in routine bloodstream isolates from children’s hospitals varies substantially from adult surveillance data in Europe. Pediatr Infect Dis J 34:734–741CrossRefPubMed
15.
go back to reference Eggimann P, Pittet D (2001) Nonantibibiotic measures for the prevention of Gram-positive infections. Clin Microb Infect 7 [Suppl 4]:91–99CrossRef Eggimann P, Pittet D (2001) Nonantibibiotic measures for the prevention of Gram-positive infections. Clin Microb Infect 7 [Suppl 4]:91–99CrossRef
16.
go back to reference Burdet C, Clermont O, Bonacorsi S et al (2014) Escherichia coli bacteremia in children: age and portal of entry are the main predictors of severity. Pediatr Infect Dis J 33:872–879CrossRefPubMed Burdet C, Clermont O, Bonacorsi S et al (2014) Escherichia coli bacteremia in children: age and portal of entry are the main predictors of severity. Pediatr Infect Dis J 33:872–879CrossRefPubMed
17.
go back to reference Sharland M, Subgroup SP (2007) The use of antibacterials in children: a report of the Specialist Advisory Committee on Antimicrobial Resistance (SACAR) Paediatric Subgroup. J Antimicrob Chemother 60 [Suppl 1]:i15–i26CrossRefPubMed Sharland M, Subgroup SP (2007) The use of antibacterials in children: a report of the Specialist Advisory Committee on Antimicrobial Resistance (SACAR) Paediatric Subgroup. J Antimicrob Chemother 60 [Suppl 1]:i15–i26CrossRefPubMed
18.
go back to reference Tamma PD, Robinson GL, Gerber JS et al (2013) Pediatric antimicrobial susceptibility trends across the United States. Infect Control Hosp Epidemiol 34:1244–1251CrossRefPubMed Tamma PD, Robinson GL, Gerber JS et al (2013) Pediatric antimicrobial susceptibility trends across the United States. Infect Control Hosp Epidemiol 34:1244–1251CrossRefPubMed
19.
go back to reference Pereira CA, Marra AR, Camargo LF et al (2013) Nosocomial bloodstream infections in Brazilian pediatric patients: microbiology, epidemiology, and clinical features. PLoS One 8:e68144CrossRefPubMedPubMedCentral Pereira CA, Marra AR, Camargo LF et al (2013) Nosocomial bloodstream infections in Brazilian pediatric patients: microbiology, epidemiology, and clinical features. PLoS One 8:e68144CrossRefPubMedPubMedCentral
20.
go back to reference Hamer DH, Darmstadt GL, Carlin JB et al (2015) Etiology of bacteremia in young infants in six countries. Pediatr Infect Dis J 34:e1–e8CrossRefPubMed Hamer DH, Darmstadt GL, Carlin JB et al (2015) Etiology of bacteremia in young infants in six countries. Pediatr Infect Dis J 34:e1–e8CrossRefPubMed
21.
go back to reference Biondi E, Evans R, Mischler M et al (2013) Epidemiology of bacteremia in febrile infants in the United States. Pediatrics 132:990–996CrossRefPubMed Biondi E, Evans R, Mischler M et al (2013) Epidemiology of bacteremia in febrile infants in the United States. Pediatrics 132:990–996CrossRefPubMed
22.
go back to reference Marra AR, Camargo LF, Pignatari AC et al (2011) Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study. J Clin Microbiol 49:1866–1871CrossRefPubMedPubMedCentral Marra AR, Camargo LF, Pignatari AC et al (2011) Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study. J Clin Microbiol 49:1866–1871CrossRefPubMedPubMedCentral
23.
go back to reference Farnham AC, Zimmerman CM, Papadouka V et al (2015) Invasive pneumococcal disease following the introduction of 13-valent conjugate vaccine in children in New York City from 2007 to 2012. JAMA Pediatr 169:646–652CrossRefPubMed Farnham AC, Zimmerman CM, Papadouka V et al (2015) Invasive pneumococcal disease following the introduction of 13-valent conjugate vaccine in children in New York City from 2007 to 2012. JAMA Pediatr 169:646–652CrossRefPubMed
24.
go back to reference Tagarro A, Benito A, Sanchez A et al (2016) Bacteremic pneumonia before and after withdrawal of 13-valent pneumococcal conjugate vaccine from a public vaccination program in Spain: a case-control study. J Pediatr 171:111–115.e3 Tagarro A, Benito A, Sanchez A et al (2016) Bacteremic pneumonia before and after withdrawal of 13-valent pneumococcal conjugate vaccine from a public vaccination program in Spain: a case-control study. J Pediatr 171:111–115.e3
25.
26.
go back to reference Mueller M, Henle A, Droz S et al (2014) Intrapartum detection of Group B streptococci colonization by rapid PCR-test on labor ward. Eur J Obstet Gynecol Reprod Biol 176:137–141CrossRefPubMed Mueller M, Henle A, Droz S et al (2014) Intrapartum detection of Group B streptococci colonization by rapid PCR-test on labor ward. Eur J Obstet Gynecol Reprod Biol 176:137–141CrossRefPubMed
27.
go back to reference Barcaite E, Bartusevicius A, Tameliene R, Kliucinskas M, Maleckiene L, Nadisauskiene R (2008) Prevalence of maternal group B streptococcal colonisation in European countries. Acta Obstet Gynecol Scand 87:260–271CrossRefPubMed Barcaite E, Bartusevicius A, Tameliene R, Kliucinskas M, Maleckiene L, Nadisauskiene R (2008) Prevalence of maternal group B streptococcal colonisation in European countries. Acta Obstet Gynecol Scand 87:260–271CrossRefPubMed
28.
go back to reference Surbek D, Henle-Gross A, Seydoux J, Honegger CH, Irion O, Drack G (2012) Prophylaxe der early-onset-Neugeborenensepsis durch Streptokokken der Gruppe B. Gynecologie Suisse, Expertenbrief No 19 Surbek D, Henle-Gross A, Seydoux J, Honegger CH, Irion O, Drack G (2012) Prophylaxe der early-onset-Neugeborenensepsis durch Streptokokken der Gruppe B. Gynecologie Suisse, Expertenbrief No 19
29.
go back to reference Giannoni E, Berger C, Stocker M et al (2016) Incidence and outcome of Group B streptococcal sepsis in infants in Switzerland. Pediatr Infect Dis J 35:222–224CrossRefPubMed Giannoni E, Berger C, Stocker M et al (2016) Incidence and outcome of Group B streptococcal sepsis in infants in Switzerland. Pediatr Infect Dis J 35:222–224CrossRefPubMed
30.
go back to reference Mermel LA (2015) Catheter tip cultures: are they really relegated to the archives of historical medical interest? Clin Infect Diseases 60:975CrossRef Mermel LA (2015) Catheter tip cultures: are they really relegated to the archives of historical medical interest? Clin Infect Diseases 60:975CrossRef
Metadata
Title
Patterns and trends of pediatric bloodstream infections: a 7-year surveillance study
Authors
N. Buetti
A. Atkinson
L. Kottanattu
J. Bielicki
J. Marschall
A. Kronenberg
the Swiss Centre for Antibiotic resistance (ANRESIS)
Publication date
01-03-2017
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 3/2017
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-016-2830-6

Other articles of this Issue 3/2017

European Journal of Clinical Microbiology & Infectious Diseases 3/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.